Stock listing

DTIL Stock Price, News, Filings & Events — Precision Biosciences, Inc.

Selected listing: DTIL · BOATS · USD · US

This page tracks Precision Biosciences, Inc.'s DTIL:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following DTIL:BOATS. DTIL:BOATS is the stock-level entry point for investors researching Precision Biosciences, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Precision Biosciences, Inc. is a publicly traded company in the American market, with a market capitalization of approximately $188 million. The company focuses on developing innovative gene editing technologies and therapies. As a leader in its field, Precision Biosciences aims to advance the treatment of various diseases through its proprietary platform.

DTIL:BOATSUSDUSUpdated September 11, 2026
Precision Biosciences, Inc. logo
Ticker
DTIL:BOATS
Asset type
Stock
Market cap
$197.9M
Sector
Health Technology
Industry
Biotechnology
Exchange
BOATS
Currency
USD

Precision Biosciences, Inc. DTIL:BOATS stock context

This page tracks Precision Biosciences, Inc.'s DTIL:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following DTIL:BOATS. DTIL:BOATS is the stock-level entry point for investors researching Precision Biosciences, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Precision Biosciences, Inc. is a publicly traded company in the American market, with a market capitalization of approximately $188 million. The company focuses on developing innovative gene editing technologies and therapies. As a leader in its field, Precision Biosciences aims to advance the treatment of various diseases through its proprietary platform.

Latest news from Precision Biosciences, Inc.

All Precision Biosciences, Inc. news →

Research Precision Biosciences, Inc.

Alternate listings